Drugs / Jinsang Liyan Capsule
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05879029 | Jul 2023 → Dec 2024 | upper respiratory tract disorder | Tongji Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Jinsang Liyan Capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05879029 ↗ |
| Route | Oral | “Jinsang Liyan Capsule: oral, 0.4g/ capsule, 4 capsules, twice a day, for 8 weeks” NCT05879029 ↗ |